Purpose: To delineate and compare the kinetics of corneal angiogenesis after high-risk (HR) versus low-risk (LR) corneal transplantation.
graft bed 2 weeks before allogeneic transplantation to induce angiogenesis and amplify the risk of graft rejection. Control (LR) graft recipients did not undergo suture placement, and thus the host bed remained avascular at the time of transplantation. Graft hemangiogenesis and opacity scores were evaluated for 8 weeks by slit-lamp biomicroscopy. Immunohistochemistry was used to measure CD31 high (blood vessels) and LYVE-1 high (lymphatic vessels) cells.
Results: Biphasic kinetics were observed for hemangiogenesis in both HR and LR transplant recipients using clinical and immunohistochemical assessments. The biphasic kinetics were composed of a rise-fall (phase 1) followed by a second rise (phase 2) in the degree of vessels. Compared with LR recipients, HR recipients showed higher hemangiogenesis (whole cornea and graft) throughout 8 weeks. Analyzing grafts revealed sustained presence of lymphatic vessels in HR recipients; however, lymphatic neovessels regressed in LR recipients 2 weeks posttransplantation. In contrast to HR host beds, the LR host bed microenvironment cannot sustain the growth of lymphatic neovessels in allografts, whereas it can sustain continued hemangiogenesis.
Conclusions:
The sustained presence of lymphatic vessels in HR host beds can facilitate host immunity against allografts and is likely associated with ongoing higher risk of rejection of these grafts in the long term, suggesting that therapeutic interventions targeting inflammation and lymphatic vessels need to be sustained long term in the HR corneal transplant setting.
Key Words: cornea transplantation, angiogenesis, hemangiogenesis, lymphangiogenesis, allograft rejection (Cornea 2017;36:491-496) N eovessel formation is often a physiological process involved in tissue repair. Tissue damage is typically followed by an inflammatory response that protects the tissue from infection and promotes wound healing. 1 The innate arm of the immune system, in particular macrophages, 2-4 facilitates wound healing by generating proangiogenic factors leading to angiogenesis. For example, we have previously shown that corneal injury leads to recruitment of vascular endothelial growth factor A-secreting macrophages and induction of hemangiogenesis. 5 Blood vessels sprout at the edge of the injury, enabling formation of granulation tissue, which consists of fibroblasts and collagen. 6 Growth and maturation of blood vessels at the site of injury is usually a tightly controlled process, and once the tissue is repaired, blood vessels regress. 7 Numerous physiological antiangiogenic factors, such as angiostatin, endostatin, tumstatin, vasohibin, fragments of prolactin, and growth hormones, facilitate this regression. 8 Regression of the vessels is in turn tightly associated with resolution of the inflammation. 9 In the context of the adaptive immune response, including in various immunopathologies seen in infection, allergy, autoimmunity, and graft rejection, inflammation and hemangiogenesis are related to the presence of antigens. [10] [11] [12] Syphilitic interstitial keratitis is an example during which blood vessels are formed on exposure to antigen and regress once antigens are cleared. 13 In atopic keratoconjunctivitis, chronic inflammation due to persistent exposure to allergen(s) promotes progressive corneal neovessel formation. 14 Neovascularization (NV) is commonly seen after corneal transplantation, especially when grafts are placed in inflamed host beds; NV is caused by both mechanical injury and inflammatory response to foreign (graft) antigens. 15 Importantly, the survival of corneal transplants can be significantly affected by the degree of the angiogenic response. [16] [17] [18] [19] [20] [21] [22] This is due to lymphatic and blood vessels acting as mediators of afferent and efferent arms of the immune system, respectively, whereby lymphatics mediate trafficking of alloantigen and immune cells from the graft to lymphoid tissues, and blood vessels facilitate homing of immune cells to the graft. [23] [24] [25] [26] In this study, we characterize the kinetics of vessel formation in the cornea in a mouse model of corneal transplantation to determine how the kinetics of neohemangiogenesis and neolymphangiogenesis differ in the 2 distinct settings: 1) low-risk (LR) recipients that have no preexisting corneal blood and lymphatic vessels and 2) high-risk (HR) recipients whose corneas have ample blood and lymphatic vessels before transplantation. 27 
MATERIALS AND METHODS

Animals
Six-week-old BALB/c (H-2d) and C57BL/6 (H-2b) male mice were purchased from Charles River Laboratories (Wilmington, MA). The mice were housed in the Schepens Eye Research Institute animal vivarium and treated according to the guidelines set forth by the Association for Research in Vision and Ophthalmology. All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee.
Suture-Induced Inflamed Graft Bed Preparation
Inflamed and neovascularized (HR) host beds were created as detailed previously. 27 First, a 1.5-mm trephine was used to mark the central corneas of BALB/c host mice. Three intrastromal figure-of-eight suture knots were placed into the central cornea using 11-0 nylon sutures (AB-0550S; MANI, Tochigi, Japan) 14 days before corneal transplantation to induce extensive NV in the host beds. Mice with unmanipulated (LR) host beds served as controls.
Allogeneic Corneal Transplantation
Allogeneic orthotopic corneal transplantation was performed as described previously. 27, 28 Briefly, the central cornea (2-mm diameter) was excised from a fully disparate donor C57BL/6 mouse using scissors (Vannas; Storz Instruments, San Dimas, CA). The graft bed was prepared by excising a 1.5-mm site of the central cornea of a BALB/c host mouse. The donor button was then placed onto the recipient bed and secured with 8 interrupted 11-0 nylon sutures. After surgery, host eyelids were closed for 3 days and interrupted corneal sutures were removed 7 days after surgery. Grafts' hemangiogenesis, opacity score, and survival rate were evaluated once a week for 8 weeks by slit-lamp biomicroscopy (magnification, ·25). We used a standardized scoring system to assess opacity (range, 0-5+) and hemangiogenesis (range, 0-8+). 27 Corneas with an opacity score of 2+ for 2 consecutive examinations were considered rejected. 27 To exclude grafts undergoing primary failure, only grafts with scores of ,2 at day 14 after transplantation were used for further analysis. Immune response-mediated rejection occurs after 14 days posttransplantation.
Corneal Whole Mount and Immunofluorescent Staining
Freshly excised corneas were washed with phosphatebuffered saline. The corneal epithelium was removed after incubation with 20-mM EDTA for 60 minutes at 37°C, fixed in acetone for 15 minutes at room temperature, and blocked in 2% bovine serum albumin for 60 minutes. Then, corneas were double stained with CD31 (Santa Cruz Biotechnology, Dallas, TX) and lymphatic vessel endothelial hyaluronan receptor (LYVE)-1 (R&D AF2125) as described previously using goat anti-mouse CD31 FITC (1:100), LYVE-1 purified goat anti-mouse (1:400) overnight. Cy3-conjugated donkey anti-goat (1:2000, Jackson ImmunoResearch Laboratories, West Grove, PA) was then added as a secondary antibody and incubated for 2 hours. Stained whole mount corneas were mounted in Vectashield with DAPI. The area covered by blood or lymphatic vessels of the total cornea or graft was then analyzed using ImageJ (See Figure 
Statistical Analyses
The two-way analysis of variance (ANOVA) test with the Bonferroni multiple comparison test was used to compare 2 groups. Correlation between NV and opacity scores was analyzed using the Spearman rank correlation test at 14 days after transplantation. Kaplan-Meier analysis was used to construct survival curves, and the log-rank test was used to compare corneal graft survival. Data are presented as mean 6 standard error of mean and considered statistically significant at *P ,0.05, **P ,0.01, and ***P ,0.001.
RESULTS
Slit-lamp examination revealed biphasic kinetics for hemangiogenesis (Figs. 1A, B) . As expected, there was a higher degree of hemangiogenesis in the corneas of HR versus LR recipients at baseline on the day of transplantation. One week posttransplantation, hemangiogenesis increased in both groups with the magnitude of the difference between the 2 groups being reduced. Interestingly, we observed a reduced hemangiogenic response 2 weeks posttransplantation (1 week after suture removal) in both groups. A second rise in hemangiogenesis was noted in both groups 3 weeks posttransplantation, which was sustained for 8 weeks. This rise was more prominent in the HR as compared to the LR recipient group (Fig. 1B , n = 10, ***P , 0.0001). The second increase in hemangiogenesis directly correlated with increased opacity scores (Fig. 1C , n = 10, ***P , 0.0001; Fig. 1D , n = 140, g = 0.84, P , 0.0001). Graft survival was significantly decreased in HR compared with LR transplants (Fig. 1E , n = 10, ***P = 0.0002).
Immunohistochemical analyses confirmed a biphasic kinetic response in blood vessel formation (Figs. 2A, B) . While in the naive cornea, we detected only a small limbal area covered with vessels (See Figure, Supplemental Digital Content 2, http://links.lww.com/ICO/A483, for the area of blood vessels in the naive cornea), and in grafted corneas, we observed increased angiogenesis by fluorescence microscopy (Figs. 2A, B , n = 10, **P , 0.01, ***P , 0.001). We noted increased vessel formation in the graft, which was significantly more pronounced in HR versus LR recipients (Figs. 2C, D , n = 10, *P , 0.05, **P , 0.01, ***P , 0.001). In LR recipients, the fraction of the graft area that was covered by blood vessels was only slightly increased shortly after transplantation and remained constant for nearly 2 weeks. A fast and significant angiogenic response was seen in HR recipients that saturated within a week after transplantation.
In contrast to blood vessels, the lymphangiogenic response was similar in HR and LR recipients when the entire corneal surface was analyzed (Figs. 3A, B , n = 10). However, when only the graft was analyzed, distinct dynamics for lymphatic ingrowth were observed (Figs. 3C , D, n = 10, *P , 0.05, ***P , 0.001). Compared with LR recipients, a significantly higher amount of lymphatic vessels was observed in grafted corneas in HR recipients 1 week after transplantation, which stayed higher throughout the follow-up FIGURE 1. NV, opacity, and graft survival in LR and HR transplant recipients. HR recipients underwent 3 intrastromal suture placements 14 days before corneal transplantation. LR recipients received no sutures before transplantation, and the corneas were left avascular and alymphatic. Corneal grafts were harvested from C57BL/6 donors and transplanted to BALB/c recipients, and the outcomes were assessed weekly for 8 weeks. A, Representative slit-lamp images showing corneas posttransplantation in vivo (magnification ·25). (B) NV scores were markedly higher in HR grafts compared with LR (2-way ANOVA, n = 10/group, ***P , 0.0001). We included all grafts in this statistics, irrespective of their survival scores. C, Graft opacity scores were markedly higher in the HR grafts compared with LR (2-way ANOVA, n = 10/group, ***P , 0.0001). D, Correlation between NV and graft opacity scores was examined by the Spearman correlation test at day 14 after corneal transplantation (n = 140, g = 0.84, P , 0.0001). E, Kaplan-Meier survival curves show a significant decrease in the survival of HR graft recipients compared with LR recipients (logrank test, n = 10/group, ***P , 0.0002). (Figs. 3C, D) . HR recipients showed a monotonically increasing trend with 3 distinct phases, a fast rise during the first week, a shallow rise during second and third weeks, and finally a delayed rise during the fourth week. The delayed rise started after 3 weeks in HR recipients, whereas in LR recipients, the lymphatic vessels regressed in both graft and host beds over 3-4 weeks posttransplantation (Figs. 3C, 3D ).
DISCUSSION
Trafficking of immune cells to and from the graft site is essential for the adaptive immune response to allografts and is established by blood and lymphatic vessels, which mediate efferent and afferent arms of the host alloimmune response, respectively. 29 The afferent arm refers to trafficking of antigen and antigen-laden immune cells that lead to host allosensitization, and the efferent arm to targeting of the graft principally by alloreactive T cells. Suppressing the amount of vessels before 22 or at the time of transplantation 20 can lead to significantly increased graft survival. Blood and lymphatic vessels also contribute to wound healing and resolution of edema, respectively. As such, understanding the dynamics of vessel formation and maintenance of neovessels is essential to understanding the timecourse of postsurgical recovery, as well as short-and long-term immune response to the grafted corneas.
HR recipients of corneal grafts are at enhanced risk for graft rejection resolution of surgery-induced tissue edema (Figs.  1B, E) . At the very early stage postgrafting, the difference between the survival rates of HR and LR grafts could potentially be attributed in part to the significantly different amounts of blood vessels already present in the host beds. However, previous studies using integrin blockade to fully suppress lymphatic vessels before transplantation resulted in reduced rejection in the HR setting, suggesting that blood vessels are not the exclusive mediators of immune rejection. 22 In contrast, our study focuses on posttransplantation angiogenic responses and reveals that LR and HR hosts have comparable lymphatic ingrowth early on, although they differ significantly in the amount of blood vessel ingrowth. In a recent publication, we have reported that inhibition of vessel formation reduces the alloimmune response and promotes graft survival. 20 A previous study using an alkali burn model has shown that corneal lymphangiogenesis develops 3 days postinjury, peaks at 2 weeks, and then decreases gradually. 30 Similar to the alkali burn model, LR graft recipients show regression of lymphatic neovessels soon after grafting (within a month). In contrast, HR recipients maintain lymphatic vessels for a long The percentage of blood vessels was calculated as follows: area covered by vessels divided by total area of cornea or graft. All data were obtained from n = 10 mice/group, and representative data from 3 independent experiments are shown. P values were calculated using the 2-way ANOVA test (*P , 0.05; **P , 0.01; ***P , 0.001). Scale bar, 500 mm.
period. Our data show that LR host beds are able to maintain blood vessels but not lymphatic vessels, in contrast to HR recipients in which significant levels of both blood and lymphatic vessels are maintained. There are 2 major implications of these findings. First, our data clearly suggest that angiogenic homeostatic mechanisms are restored much earlier in LR, as opposed to HR graft recipients. Specifically, lymphatic responses regress early in noninflamed LR hosts, as described similarly using an alkali burn model. 30 Related to this is the corollary that interventions targeting inflammation and lymphangiogenesis need to be maintained long term in HR transplantation given that hosts with long-term unrestrained lymphatics will remain at risk for ongoing allosensitization and rejection for prolonged periods.
